EUVIMEDEUVIMED entdecken
Crossref

ANRIL regulates retinoblastoma progression via targeting autophagy by miR-328-3p/TSC1/ULK signaling

Yang Yang, Yuezhi Zhang, Yanmei Fu, Shuanglian Li, Xiaolong Yin

Polish Journal of Pathology · 2024

DOI: 10.5114/pjp.2024.142177 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Polish Journal of Pathology, 2024. Verfasst von Yang Yang und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmic Center, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China. Hauptthemen laut MEDLINE: MicroRNAs, RNA, Long Noncoding, Autophagy, Retinoblastoma. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Retinoblastoma is the most common primary intraocular malignancy of childhood. The aim of our study was to investigate the role and regulatory mechanism of the long non-coding RNA ANRIL in retinoblastoma. Here, our data demonstrated that ANRIL overexpression inhibited miR-328-3p expression, but promoted expression of autophagy-related proteins (LC3B, ATG5, and BECN1). Then we predicted the binding sites for ANRIL with miR-328-3p, and for miR-328 3p with TSC1/ULK2 3'-UTR, and confirmed the combination of miR-328-3p and ANRIL and TSC1/ULK2 3'-UTR. Importantly, the data showed that ANRIL overexpression promoted TSC1 and ULK2 expression, and inhibited the phosphorylation of mTOR. Finally, our results indicated that ANRIL overexpression facilitated Y79 cell proliferation and cisplatin-induced apoptosis. Our results indicated that ANRIL promoted the proliferation and cisplatin resistance of Y79 cells through activating autophagy by promoting TSC1/ULK2 ex- pression via acting as a miR-328-3p sponge.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MicroRNAsRNA, Long NoncodingAutophagyRetinoblastomaRetinal NeoplasmsSignal TransductionTuberous Sclerosis Complex 1 ProteinCell ProliferationHumansCell Line, TumorGene Expression Regulation, NeoplasticApoptosisDrug Resistance, NeoplasmDisease ProgressionCisplatinProtein Serine-Threonine Kinases

Stichwörter der Autor:innen

cisplatin resistancecompeting endogenous RNAlong non-coding RNAproliferationretinoblastoma

Substanzen

MicroRNAsRNA, Long NoncodingCDKN2B antisense RNA, humanTuberous Sclerosis Complex 1 ProteinTSC1 protein, humanUlk2 protein, humanCisplatinProtein Serine-Threonine Kinases

Autor:innen und Institutionen

  • Department of Ophthalmic Center, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China.

Zitieren

APA

Yang, Y., Zhang, Y., Fu, Y., Li, S., & Yin, X. (2024). ANRIL regulates retinoblastoma progression via targeting autophagy by miR-328-3p/TSC1/ULK signaling. Polish Journal of Pathology. https://doi.org/10.5114/pjp.2024.142177

Vancouver

Yang Y, Zhang Y, Fu Y, Li S, Yin X. ANRIL regulates retinoblastoma progression via targeting autophagy by miR-328-3p/TSC1/ULK signaling. Polish Journal of Pathology. 2024. doi:10.5114/pjp.2024.142177

BibTeX
@article{Yang2024,
  author = {Yang, Yang and Zhang, Yuezhi and Fu, Yanmei and Li, Shuanglian and Yin, Xiaolong},
  title = {ANRIL regulates retinoblastoma progression via targeting autophagy by miR-328-3p/TSC1/ULK signaling},
  journal = {Polish Journal of Pathology},
  year = {2024},
  doi = {10.5114/pjp.2024.142177}
}
Kostenlos starten →